Taken together, the efficacious combination of OVV and DOX produces changes in CREB3L1 signaling pathways associated with the nuclear translocation of this factor in cancer cells and identify a mechanism of improving the effectiveness of DOX-based chemotherapy for EOC patients, while also providing the potent therapeutic benefits of viral oncotherapy. This evidence concerns the gene CREB3L1 and cancer.